Oxidative Stress in Pulmonary Fibrosis

Area of Science:

• Pulmonary Medicine
• Cellular Biology
• Aging Research

Background:

• Oxidative stress is implicated in aging and various diseases.
• The lungs' unique exposure to oxidants necessitates robust antioxidant defenses.
• Idiopathic pulmonary fibrosis (IPF) is a fatal, age-related lung disease characterized by fibrosis.

Purpose of the Study:

• To review the role of oxidative stress in the pathogenesis of IPF.
• To link oxidative stress to the biological mechanisms of aging.
• To discuss current and future therapeutic strategies targeting oxidative stress in fibrosis.

Main Methods:

• Literature review of cellular oxidant production and antioxidant defenses.
• Analysis of the contribution of reactive oxygen species (ROS) to fibrotic processes.
• Examination of the connection between oxidative stress and aging hallmarks.
• Overview of preclinical and clinical studies on antioxidant therapies for fibrosis.

Main Results:

• Oxidative stress is a key driver of IPF pathogenesis, affecting multiple cell types and processes.
• ROS contribute to macrophage polarization, epithelial cell apoptosis/senescence, myofibroblast differentiation, and extracellular matrix alterations.
• Aging processes like DNA damage, loss of proteostasis, and mitochondrial dysfunction are linked to oxidative stress.
• Current research explores targeting oxidative stress pathways for IPF treatment.

Conclusions:

• Oxidative stress plays a critical role in the development and progression of idiopathic pulmonary fibrosis.
• Understanding the interplay between oxidative stress, aging, and fibrosis is crucial for developing effective therapies.
• Targeting ROS and enhancing antioxidant defenses represent promising therapeutic avenues for IPF.